Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEnanta Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.58 | -$0.54 | -$0.56 |
| Q2 2026 | 3 | -$0.58 | -$0.55 | -$0.56 |
| Q3 2026 | 1 | -$0.87 | -$0.65 | -$0.75 |
| Q4 2026 | 1 | -$0.67 | -$0.50 | -$0.58 |
| Q1 2027 | 1 | -$0.68 | -$0.51 | -$0.59 |
| Q2 2027 | 1 | -$0.68 | -$0.51 | -$0.59 |
| Q3 2027 | 1 | -$0.74 | -$0.55 | -$0.64 |
Enanta Pharmaceuticals Inc Earnings Date And Information
Enanta Pharmaceuticals Inc last posted its earnings results on Monday, February 9th, 2026. The company reported $-0.42 earnings per share for the quarter, topping analysts' consensus estimates of $-0.54 by $0.12. The company had revenue of 18.62 M for the quarter and had revenue of 65.32 M for the year. Enanta Pharmaceuticals Inc has generated $-4 earnings per share over the last year ($-3.84 diluted earnings per share) and currently has a price-to-earnings ratio of -4.18. Enanta Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Enanta Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q1 2026 | N/A | -$0.56 | N/A | $15.90 M | $18.62 M |
| 11/19/2025 | Q4 2025 | N/A | -$0.87 | N/A | $15.98 M | $15.13 M |
| 08/13/2025 | Q3 2025 | N/A | -$0.86 | N/A | $15.54 M | $18.31 M |
| 05/14/2025 | Q2 2025 | N/A | -$1.06 | N/A | $15.95 M | $14.93 M |
| 02/12/2025 | Q1 2025 | N/A | -$1.05 | N/A | $17.25 M | $16.96 M |
| 11/27/2024 | Q4 2024 | N/A | -$1.36 | N/A | $17.93 M | $14.61 M |
| 08/07/2024 | Q3 2024 | N/A | -$1.07 | N/A | $17.44 M | $17.97 M |
| 05/08/2024 | Q2 2024 | N/A | -$1.47 | N/A | $16.09 M | $17.05 M |
| 02/08/2024 | Q1 2024 | N/A | -$1.58 | N/A | N/A | $18.00 M |
| 11/22/2023 | Q4 2023 | N/A | -$1.33 | N/A | N/A | $18.93 M |
| 08/08/2023 | Q3 2023 | N/A | -$1.86 | N/A | N/A | $18.89 M |
| 05/09/2023 | Q2 2023 | N/A | -$1.79 | N/A | N/A | $17.80 M |
| 02/08/2023 | Q1 2023 | N/A | -$1.39 | N/A | N/A | $23.59 M |
| 11/23/2022 | Q4 2022 | N/A | -$1.28 | N/A | N/A | $20.32 M |
| 08/08/2022 | Q3 2022 | -$1.36 | -$1.53 | -0.17 | N/A | $19.48 M |
| 05/09/2022 | Q2 2022 | -$1.43 | -$1.63 | -0.2 | N/A | $18.72 M |
| 02/09/2022 | Q1 2022 | N/A | -$1.48 | N/A | N/A | $27.65 M |
| 11/24/2021 | Q4 2021 | N/A | -$1.22 | N/A | N/A | $23.58 M |
| 08/09/2021 | Q3 2021 | N/A | -$1.19 | N/A | N/A | $21.62 M |
| 05/10/2021 | Q2 2021 | N/A | -$1.09 | N/A | N/A | $20.13 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enanta Pharmaceuticals Inc Earnings: FAQ's
In the previous quarter, Enanta Pharmaceuticals Inc (:ENTA) reported $-0.42 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.54 by $0.12.
The conference call for Enanta Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Enanta Pharmaceuticals Inc's latest earnings report can be read online.
Enanta Pharmaceuticals Inc (:ENTA) has a recorded annual revenue of $65.32 M.
Enanta Pharmaceuticals Inc (:ENTA) has a recorded net income of $-81,889,000.Enanta Pharmaceuticals Inc has generated $-3.84 earnings per share over the last four quarters.
Enanta Pharmaceuticals Inc (:ENTA) has a price-to-earnings ratio of -4.18 and price/earnings-to-growth ratio is -0.33.